Results 1 to 10 of about 3,362,668 (327)

Antipsychotic agents: efficacy and safety in schizophrenia [PDF]

Drug, Healthcare and Patient Safety, 2012
Arão Nogueira de Araújo,1 Eduardo Pondé de Sena,1,2 Irismar Reis de Oliveira,1,3 Mario F Juruena41Postgraduation Program in Interactive Processes of Organs and Systems, 2Department of Pharmacology, Institute of Health ...
de Araújo AN, de Sena EP, de Oliveira IR, Juruena MF   +3 more
doaj   +5 more sources

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia

Neuropsychiatric Disease and Treatment, 2009
Xinhua S Ren1,2,3, Lawrence Herz4,5, Shirley Qian1,2,3, Eric Smith3,4, Lewis E Kazis1,2,31The Center for the Assessment of Pharmaceutical Practices (CAPP), Boston University School of Public Health, Boston, MA, USA; 2Department of ...
Xinhua S Ren, Lawrence Herz, Shirley Qian, et al   +3 more
doaj   +4 more sources

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System. [PDF]

Front Pharmacol, 2022
Treatment of central nervous system (CNS) disorders is challenging using conventional delivery strategies and routes of administration because of the presence of the blood–brain barrier (BBB). This BBB restricts the permeation of most of the therapeutics
Pandey M, Jain N, Kanoujia J, Hussain Z, Gorain B.   +4 more
europepmc   +2 more sources

Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity. [PDF]

PLoS One, 2018
Bacterial antibiotic resistance is an emerging public health problem worldwide; therefore, new therapeutic strategies are needed. Many studies have described antipsychotic compounds that present antibacterial activity.
Nehme H, Saulnier P, Ramadan AA, Cassisa V, Guillet C, Eveillard M, Umerska A.   +6 more
europepmc   +2 more sources

Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents. [PDF]

Tremor Other Hyperkinet Mov (N Y), 2022
Kannarkat GT, Caroff SN, Morley JF.
europepmc   +3 more sources

Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia. [PDF]

Curr Ther Res Clin Exp, 2023
Fares J, Mohamed F, Yosra Z, Oumaya H, Riadh B, Jihenne M.   +5 more
europepmc   +2 more sources

Association between antipsychotic agents and risk of lung cancer: a nested case-control study. [PDF]

Cancer Commun (Lond), 2022
Li J, Tang F, Si S, Xue F.
europepmc   +2 more sources

Preferences for Selecting and Initiating Long-Acting Injectable Antipsychotic Agents for the Treatment of Patients With Schizophrenia: Results From the US DECIDE Survey. [PDF]

Schizophr Bull Open
Velligan D, Salinas GD, Belcher E, Franzenburg KR, Suett M, Thompson S, Hansen RT.   +6 more
europepmc   +3 more sources

Reply: Antipsychotic Agents and Delirium. [PDF]

Am J Respir Crit Care Med, 2015
Hsieh SJ, Soto GJ, Hope AA, Ponea A, Gong MN.   +4 more
europepmc   +2 more sources

ANTIPSYCHOTIC AGENTS IN ANXIETY DISORDERS: AN UMBRELLA REVIEW [PDF]

Int J Neuropsychopharmacol
Rafael C. Freire, Amir Garakani, Frank D. Buono, Mona Salehi, Melissa Funaro, Anna Klimowicz, Harshit Sharma, Clara V. Faria, Kaitlyn Larkin   +8 more
europepmc   +2 more sources